These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8197797)

  • 1. [Is pathogenetically-founded therapy of chronic inflammatory bowel disease in sight?].
    Miller B
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():30-4. PubMed ID: 8197797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of chronic inflammatory bowel diseases].
    Peskar BM
    Verh Dtsch Ges Inn Med; 1990; 96():706-12. PubMed ID: 2092510
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical treatment of inflammatory bowel disease.
    Singhal A; Kar P
    J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067
    [No Abstract]   [Full Text] [Related]  

  • 4. Fight back against inflammatory bowel disease.
    Day MW
    Nursing; 2008 Nov; 38(11):34-41; quiz 42. PubMed ID: 18989203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent knowledge of the pathophysiology of inflammation in Crohn disease and ulcerative colitis: possible sequelae for future treatment concepts].
    Allgayer H; Kruis W
    Z Gastroenterol; 1990 Feb; 28(2):117-20. PubMed ID: 2181785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of inflammatory bowel disease.
    Stenson WF
    Year Immunol; 1985; ():214-8. PubMed ID: 3033942
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical management of specific clinical presentations.
    Bitton A; Peppercorn MA
    Gastroenterol Clin North Am; 1995 Sep; 24(3):541-58. PubMed ID: 8809235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of chronic inflammatory bowel diseases. Basic drug therapy].
    Riemann JF
    Verh Dtsch Ges Inn Med; 1988; 94():175-8. PubMed ID: 3061190
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
    Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
    Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of chronic inflammatory bowel diseases. Long-term ambulatory care].
    Rohr G
    Verh Dtsch Ges Inn Med; 1988; 94():212-5. PubMed ID: 3144811
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the endogenous leukotriene system in chronic inflammatory bowel disease.
    Dreyling KW; Kozuschek W; Schaarschmidt K; Goebell H; Peskar BM
    Prog Clin Biol Res; 1987; 242():309-15. PubMed ID: 2823278
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.
    Lobos EA; Sharon P; Stenson WF
    Dig Dis Sci; 1987 Dec; 32(12):1380-8. PubMed ID: 2826090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine therapy in inflammatory bowel disease: open-label experience.
    Lichtiger S
    Mt Sinai J Med; 1990 Oct; 57(5):315-9. PubMed ID: 2096279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic inflammatory bowel diseases. Do antihistaminics reduce the need for steroids?].
    MMW Fortschr Med; 2000 Jun; 142(22):59. PubMed ID: 10870388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inflammatory bowel disease: anti-TNF strategies and beyond].
    Hoffmann JC
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S76-8. PubMed ID: 15368175
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine therapy for inflammatory bowel disease.
    Sartor RB
    N Engl J Med; 1994 Jun; 330(26):1897-8. PubMed ID: 8196735
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic inflammatory bowel diseases. No fear with powerful preventive drugs].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Nov; 142(45):18. PubMed ID: 11107819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methotrexate in therapy of chronic inflammatory bowel diseases].
    Schröder O; Stein J
    Z Gastroenterol; 1996 Jul; 34(7):457-8. PubMed ID: 8928541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.